PFAS and other emerging contaminants pose evolving risks to community health, and today’s funding environment offers a rare opportunity to address them smarter, faster, and more affordably. CIP partners with public agencies to leverage billions in available federal and state grants, including the limited-window infrastructure bill funding, to deploy advanced treatment technologies with smaller footprints, lower capital costs, and reduced long-term operating expenses. Whether upgrading existing systems or re-engineering outdated designs for better performance, our end-to-end delivery model helps communities maximize funding, minimize lifecycle costs, and achieve long-term protection through outcome-backed execution.